Results 201 to 210 of about 58,085 (295)

Dipeptidyl Peptidase-4 Inhibitor-associated Bullous Pemphigoid: Recurrence with Epitope Spreading

Acta Dermato-Venereologica, 2018
Hiroyuki Takama, Makiko Yoshida, Kentaro Izumi, Takeshi Yanagishita, Jun Muto, Yuichiro Ohshima, Wataru Nishie, Hiroshi Shimizu, Masashi Akiyama, Daisuke Watanabe   +9 more
doaj   +1 more source

Rurality is associated with lower likelihood of dipeptidyl peptidase 4 inhibitor use for treatment intensification. [PDF]

Explor Res Clin Soc Pharm
Nagy DK, Bresee LC, Eurich DT, Simpson SH.   +3 more
europepmc   +1 more source

Dipeptidyl-peptidase 4 inhibitor increased and maintained platelet count in a patient with primary myelofibrosis. [PDF]

EJHaem, 2021
Kaneko S, Onda Y, Sakamoto S, Okada M, Anzai N.   +4 more
europepmc   +1 more source

4-Amino cyclohexylglycine analogues as potent dipeptidyl peptidase IV inhibitors

, 2003
Emma R. Parmee, Jiafang He, Anthony Mastracchio, Scott D. Edmondson, Larry Colwell, George J. Eiermann, William P. Feeney, Bahanu Habulihaz, Huaibing He, Ruth Kilburn, Barbara Leiting, Kathryn A. Lyons, Frank Marsilio, Reshma A. Patel, Aleksandr Petrov, Jerry Di Salvo, Joseph K. Wu, Nancy A. Thornberry, Ann E. Weber   +18 more
openalex   +1 more source

Efficacy and safety of the dipeptidyl peptidase‐4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin

Diabetes, obesity and metabolism, 2007
K. Hermansen, M. Kipnes, E. Luo, D. Fanurik, H. Khatami, P. Stein   +5 more
semanticscholar   +1 more source

A case of immunoglobulin G4-related kidney disease manifesting after dipeptidyl peptidase-4 inhibitor treatment. [PDF]

CEN Case Rep
Ubara Y, Takeuchi T, Hasegawa E, Sekine A, Inoue N, Tanaka K, Mizuno H, Oba Y, Yamanouchi M, Suwabe T, Kono K, Kinowaki K, Ohashi K, Yamaguchi Y, Sawa N, Wada T.   +15 more
europepmc   +1 more source

Association between dipeptidyl peptidase-4 inhibitor use and risk of Parkinson's disease among patients with diabetes mellitus: a retrospective cohort study. [PDF]

Aging (Albany NY)
Huang KH, Yang Y, Gau SY, Tsai TH, Lee CY.   +4 more
europepmc   +1 more source

Role of anagliptin, a dipeptidyl peptidase-4 inhibitor, in managing type 2 diabetes: A systematic review and meta-analysis. [PDF]

Medicine (Baltimore)
Kamrul-Hasan ABM, Dutta D, Nagendra L, Sharma M, Patra S, Bhattacharya S.   +5 more
europepmc   +1 more source

Novel series of 3-amino-N-(4-aryl-1,1-dioxothian-4-yl)butanamides as potent and selective dipeptidyl peptidase IV inhibitors

, 2012
A. Nitta, H. Fujii, Satoshi Sakami, Mikiya Satoh, Junko Nakaki, Shiho Satoh, Hiroki Kumagai, Hideki Kawai   +7 more
openalex   +1 more source

Investigation of Glucose Metabolism by Continuous Glucose Monitoring and Validation of Dipeptidyl Peptidase 4 Inhibitor Use in Patients with Myotonic Dystrophy Type 1. [PDF]

J Clin Med
Takada H, Matsumura T, Shimamura H, Matsui M, Kon S, Fukumoto A, Kubota T, Yoshida K, Iwahashi H, Takahashi MP.   +9 more
europepmc   +1 more source